Taken together, our research has proposed that DSS can alleviate TGF-β1 – and BLM-induced PF via inhibiting the conversion of fibroblasts to myofibroblasts, possibly through suppressing the MEK/ERK signaling pathway. This evidence concerns the gene TGFB1 and Bloom syndrome.